(Q56909623)
Statements
CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers (English)
P M Wallace
J S Johnson
J F MacMaster
K A Kennedy
P Gladstone
1 September 1994